Profund Advisors’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $314K | Sell |
15,425
-7,220
| -32% | -$147K | 0.01% | 665 |
|
|
2025
Q1 | $411K | Sell |
22,645
-6,789
| -23% | -$123K | 0.02% | 544 |
|
|
2024
Q4 | $744K | Buy |
29,434
+10,873
| +59% | +$275K | 0.03% | 362 |
|
|
2024
Q3 | $631K | Sell |
18,561
-3,945
| -18% | -$134K | 0.02% | 444 |
|
|
2024
Q2 | $833K | Sell |
22,506
-7,841
| -26% | -$290K | 0.03% | 351 |
|
|
2024
Q1 | $1.27M | Buy |
30,347
+5,861
| +24% | +$246K | 0.05% | 296 |
|
|
2023
Q4 | $971K | Sell |
24,486
-3,553
| -13% | -$141K | 0.04% | 331 |
|
|
2023
Q3 | $772K | Sell |
28,039
-9,382
| -25% | -$258K | 0.04% | 345 |
|
|
2023
Q2 | $1.27M | Buy |
37,421
+10,049
| +37% | +$341K | 0.07% | 263 |
|
|
2023
Q1 | $985K | Buy |
+27,372
| New | +$985K | 0.06% | 305 |
|